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1. Introduction 
Stigma is a widely researched concept, with public stigma and self-stigma frequently cited as 
problems by those experiencing mental health issues (Corrigan et al., 2005). Goffman (1986) 
described stigma as a negative evaluation of an individual as ‘tainted’ because of attributes such as 
mental disorder, disability, or ethnicity. Public stigma is typically described as a process of prejudice, 
stereotypes and discrimination towards the stigmatised group or individual, and self-stigma is the 
internalisation of these negative attitudes, beliefs and behaviour. Internalised stigma has recently 
been defined as “becoming aware of the label and identifying with the stereotypes” (Link et al., 
2004) or “the internalisation of shame, blame, hopelessness, guilt and fear of discrimination 
associated with mental illness” (Corrigan and Watson, 2002). People with psychosis report 
internalising public stigma and experience shame and fear as a consequence, and recent research 
high levels of patients with schizophrenia report moderate to high levels of internalised stigma 
(Brohan et al., 2010).  
 Early studies found that people with mental health problems expect to experience 
discrimination and receive ill-treatment from others, have less life satisfaction because of stigma, 
and feel demoralised and rejected by others (Link, 1987; Link et al., 1989; Mansouri and Dowell, 
1989; Herman, 1993),  and suggest that self-stigma results in reduced self-esteem, increases 
depression and anxiety and hinders recovery (Schulze and Angermeyer, 2003). Recent research has 
found a strong negative relationship between internalised stigma and a range of outcomes including 
hope, self-esteem and empowerment, and a strong positive relationship with psychiatric symptoms 
(Livingston and Boyd, 2010). Internalised stigma has also been shown to increase symptoms of 
schizophrenia and reduce insight, further impeding recovery from psychosis  (Lysaker et al., 2007b). 
Additionally, such stigma discourages people from seeking help, which may delay treatment, leads 
to social isolation, and acts as a mechanism of social exclusion, which hampers recovery (Link et al., 
1997a, 2001). A recent Delphi study which examined consensus in a large sample of service users 
with psychosis about factors that promote or inhibit recovery found that they highlighted stigma as a 
potential barrier to recovery, including discrimination such as not being able to gain employment 
(Law and Morrison, 2014). 
It has been suggested that people who experience psychosis are one of the most stigmatised 
minority groups in society (Wood et al., 2014a, 2014b) with the Schizophrenia Commission (2012) 
recently reporting that 87% of individuals with a schizophrenia diagnosis had experienced stigma 
and discrimination. Research has repeatedly shown that the majority of the general public hold 
negative beliefs about people experiencing psychosis; and particularly those diagnosed with 
schizophrenia. For example, in a survey of a thousand French citizens on their attitudes towards 
people with mental illness, it was found that 69% of individuals would engage in social-distancing 
from individuals with schizophrenia, compared to 29% for bipolar disorder and 7% with autism (p 
<0.001)(Durand-Zaleski et al., 2012). The primary reason given for this discrepancy was a belief that 
individuals with schizophrenia are highly dangerous. Other studies not only support this observation 
that people diagnosed with schizophrenia are considered dangerous, but also that they are 
considered unpredictable (Crisp et al., 2000; Walker and Read, 2002; Stuart et al., 2012), 
incompetent, to blame for their illness (Corrigan and Kleinlein, 2005) and unlikely to ever recover 
(Crisp et al., 2000).  
These kinds of stigmatising attitudes create a vicious circle of disability and disadvantage 
through diminishing quality of life (Stolzman, 1994), preventing help-seeking and engagement with 
mental health services and treatment (Thornicroft et al., 2007), inhibiting social roles, increasing 
social exclusion and hindering social integration (Link et al., 1997b, 2001; Thornicroft et al., 2007). 
Individuals also experience reduced life, work and education opportunities (Thornicroft et al., 2009) 
leaving people feeling ashamed and unwilling to disclose their illness for fear of the repercussions, 
and questioning their value as a member of society (Jenkins and Carpenter-Song, 2009). This all has a 
potential impact on recovery in terms of regaining a sense of quality of life and wellbeing, so that 
individuals report feeling pessimistic about recovery and lacking hope for the future (González-
Torres et al., 2007).  
It is evident that the impact of stigma and self-stigma are far-reaching. It is possible that the 
effects of internalising stigma could be ameliorated by therapeutic interventions if the processes by 
which stigma impacts on recovery were better understood. Two likely mechanisms, to be 
investigated in the current study, are self-esteem and hopelessness. Indeed, low self-esteem and 
hopelessness are often important elements of psychotic patients’ pessimism about their own illness 
(Pitt et al., 2007) and both have previously been identified as responses to stigma (Link et al., 2001; 
González-Torres et al., 2007). Modern cognitive accounts of positive symptoms, particularly 
paranoid delusions, emphasize the important role of self-esteem in driving symptoms (Bentall et al., 
2001; Freeman et al., 2002). Moreover, the role of hopelessness in driving suicidal thinking is well 
documented (Heilä et al., 1997; King et al., 2001; Nordentoft et al., 2002). 
Hence, the aim of the present study is to investigate how stigma relates to outcome, 
whether these effects are short term (immediate) or long-term (6-months), and whether 
relationships between stigma and outcome are mediated by self-esteem or hopelessness. 
 
2. Methods 
2.1. Participants and design 
Eighty service-users (49 male, 31 female, mean age = 39.15, SD = 11.56) with experiences of 
psychosis were recruited from 5 NHS trusts in the North-West UK. All participants had a sufficient 
level of English literacy to complete the measures and capacity to provide informed consent. The 
majority were White British (75%). Participants were recruited from early intervention services 
(n=12), community mental health teams (n=61), assertive outreach teams (n=3) and other mental 
health services (n=4). Data for all measures were collected at baseline, and the outcome measures 
were administered a second time six months later. All data was collected as part of the wider 
Recovery Programme. 
 
2.2. Measures 
For the present analyses we focused on data pertaining to the key concepts of stigma and 
recovery, with the influence of hopelessness and self-esteem considered as mediators. Other 
measures which will be reported in later papers are not discussed here. 
2.2.1. Independent variables  
Stigma 
The King et al. Stigma Scale (KSS; 2007) is a 28-item self-report questionnaire with items 
rated on a scale of 0 (strongly disagree) to 4 (strongly agree). There are three sub-scales: 
Discrimination (12 items), Disclosure (11 items), and Potential Positive Aspects of mental illness (5 
items). King et al. (2007) found all items to have a test-retest reliability kappa coefficient of 0.4 or 
greater. Cronbach’s α for Discrimination was reported to be 0.87, for Disclosure 0.85, and for 
Positive Aspects 0.64. Alpha coefficients for all scales in the current sample are given in Table 1. It 
can be seen that, whereas the coefficients for Discrimination and Disclosure in this study were 
acceptable, that for Positive Aspects was not; therefore this subscale (which was short and, in any 
case, of less theoretical interest than the others) was not employed in subsequent analyses. 
2.2.2. Mediator variables  
Hopelessness 
The Beck Hopelessness Scale (BHS; Beck et al., 1974) is a 20 item self-report measure which 
measures three aspects of hopelessness: feelings about the future, loss of motivation, and negative 
expectations. Participants rate each statement as true or false for their attitudes over the last week. 
The psychometric properties of the BHS have been examined in a number of studies and it has 
demonstrated good validity and reliability (Young et al., 1993; Dyce, 1996; Nunn et al., 1996). 
Self-esteem 
The Self Esteem Rating Scale—short form (SERS; Lecomte et al., 2006) is a 20-item self-
report measure assessing positive and negative beliefs about the self. Items are rated on a 7 point 
Likert scale ranging from “never” to “always”. The scale has demonstrated good reliability and 
adequate validity. As the positive and negative totals for the self-esteem rating scale are so highly 
correlated (r=-.65, p=<.01) for the purpose of the regression and mediation analyses we extracted 
the principle component of the two subscales to yield a single scale score. 
 
2.2.3. Outcome variables  
Subjective recovery 
The Questionnaire about the Process of Recovery (QPR; Neil et al., 2009) is a 22-item self-
report measure developed in collaboration with service-users and clinicians. Items are rated on a 
five point Likert scale ranging from “strongly disagree” to “strongly agree”. Higher scores on the 
measure are indicative of greater sense of recovery. The QPR has two subscales: intrapersonal (17 
items) and interpersonal (5 items). Good internal consistency was reported for these subscales by 
the authors (intrapersonal α = 0.94; interpersonal α = 0.77) as well as good construct validity and 
test-retest reliability. 
Symptomatic recovery 
The Positive and Negative Syndrome Scale (PANSS; Kay et al., 1987, 1989) is a 30 item semi-
structured clinical interview and rating scale which includes 7 items to evaluate positive symptoms 
(e.g. delusions), 7 items to evaluate negative symptoms (e.g. blunted affect) and 16 items to assess 
global psychopathology (e.g. anxiety). Symptoms are rated by the interviewer from 1 (not present) 
to 7 (severe). The PANSS has been used in many studies and has been shown to have good reliability 
and validity. 
We tested whether the stigma variables predicted PANSS subscale (positive, negative and 
general) at baseline and follow-up. However, we also hypothesized that stigma would relate to 
particular PANSS items. Items 1 (delusions) and 6 (suspiciousness/persecution), from the PANSS 
positive subscale were expected to relate to stigma as experiences of discrimination and prejudice, 
as past research has found that experiences of discrimination predicted the later development of 
paranoid symptoms (Janssen et al., 2003). As guilt and shame are often cited in the process of 
experiencing and internalising stigma (Link et al., 2004; Scheff, 2013), item 3 (guilt feelings) from the 
PANSS general subscale was considered individually in relation to stigma. Similarly, as stigma is often 
linked to a withdrawal from social interaction (Yanos et al., 2008) item 16 (active social avoidance) 
from the general PANSS subscale, and item 4 (social withdrawal) from the negative PANSS subscale 
were examined.  
2.3. Procedure  
The study was approved by an NHS Research Ethics Committee, and was designed with the 
advice of a service-user reference group. Participants were recruited through posters, 
advertisements and referrals from health professionals. Mental health services and voluntary sector 
agencies across the North West were approached for suitable referrals to ensure diversity in 
experience of psychosis and service provision. All participants gave informed consent. To reduce 
participant burden, participants were given the option to complete some or all of the measures.  
2.4. Statistical analyses 
We hypothesised that stigma would negatively affect recovery beliefs. That is, the more 
stigma experienced, the less recovered a person would feel. We also hypothesised that the variables 
self-esteem and hopelessness would mediate this relationship. In terms of symptoms, we 
hypothesised that the individual symptoms of interest from the PANSS would be predicted by stigma 
at baseline and longitudinally at six months.  
All analyses were conducted using SPSS (version 21).  We examine bivariate relationships 
between the variables (including the KSS subscales) and Cronbach’s alpha coefficient was used to 
estimate the reliability of the measures. In subsequent linear regression models, only KSS total 
scores were considered in the light of the high correlations between total scores and subscale 
scores, and also in order to reduce the risk of type-1 error proliferation.  
If it was found that the potential mediators appeared to have an effect in the multiple 
regressions, mediational models were tested with the KSS discrimination and disclosure subscales 
using the PROCESS macro on SPSS 21 (Hayes, 2013). For this purpose, the direct effects (c paths) 
between stigma and the dependent variables (QPR or PANSS scores at baseline and at six months) 
were firstly estimated. The mediating variables (self-esteem and hopelessness) were then 
introduced, generating models with direct effects between the independent variables and the 
mediators (a paths), direct effects between the mediators and dependent variables (b paths), and 
direct effects between the independent and dependent variables whilst controlling for the 
mediators (c’ paths). The six-month follow-up models controlled for the baseline recovery beliefs or 
PANSS data as appropriate. Similarly, each stigma sub-scale mediation model controlled for the 
other sub-scale to account for its influence. This allowed us to look at the influence of each sub-scale 
individually whilst acknowledging them as part of the overall experience of stigma. The models were 
estimated using maximum likelihood (ML) estimators. As mediation models are sensitive to 
parametric assumptions and we had a relatively modest sample size, the statistical significance of 
mediating and indirect effects was examined with bootstrapped bias-corrected percentile-based 
confidence intervals of 1,000 bootstrap draws. In cases where zero did not fall within the 95 per cent 
intervals of the bootstrapped samples, the mediating effect was considered to be significant 
(MacKinnon et al., 2004, 2007; Preacher and Hayes, 2008). 
 
 
3. Results 
3.1. Correlation analysis 
 Table 1 show the correlation matrix between stigma, self-esteem, hopelessness and the 
recovery measures (QPR and PANSS) for the sample. As expected both total stigma and the 
remaining sub-scales, discrimination and disclosure, highly correlate with the QPR at baseline and at 
six months. Similarly, hopelessness and self-esteem correlate with QPR at both time-points.  
                                                          INSERT TABLE 1  
 
Perhaps unsurprisingly, significant relationships were evident between the subjective sense of 
recovery measure (QPR) and the symptom-based recovery measure (PANSS). Total stigma correlated 
with PANSS positive and general subscales scores at baseline, but only with the PANSS general 
subscale score at follow-up. The discrimination sub-scale correlated with PANSS general at both time 
points but only PANSS positive at 6 months follow-up. The disclosure subscale correlated only with 
the PANSS baseline scores. 
Positive, negative and general PANSS all display significant associations with self-esteem and 
hopelessness at baseline. At six months these relationships remain for positive and general PANSS 
scores, and become non-significant for negative PANSS scores. 
3.2. Linear regression analyses 
3.2.2 Subjective recovery 
 
 The upper portion of Table 2 show the results for regression models calculated with total 
stigma as a predictor of baseline recovery. The stigma variable was entered first and then the self-
esteem and hopelessness measures were entered afterwards. Stigma predicted subjective recovery 
at baseline, F[1,70] = 14.31, p < .001, adjusted R2 =  .16, but, when self-esteem and hopelessness 
were entered into the model, the model improved, F[2,68]change = 18.98, p < .001, leading to a final 
significant model, F[3,68] = 19.88, p < .001, adjusted R2 = .44, in which both self-esteem and 
hopelessness became significant predictors and the effect for stigma was no longer significant. The 
lower portion of Table 2 shows similar models calculated for subjective recovery scores at the six-
month follow-up.  In the case of these data, predictors were entered in three stages: first, the 
baseline recovery scores, then stigma, and finally the hypothesised mediators. The second stage in 
these models therefore indicates whether stigma predicts subjective recovery at six months even 
when baseline subjective recovery is controlled for. The addition of KSS total scores led to a 
significantly better model than the baseline scores alone, F[1,48]change = 4.41, p < .04, leading to a 
significant model, F[2,48] = 21.41, p < .001, adjusted R2 = .45, in which stigma was a significant 
predictor. However, adding self-esteem and hopelessness did not lead to a further improvement in 
the model.  
 
INSERT TABLE 2 
 
 Overall, these findings indicate that current experiences of stigma strongly predict current 
recovery judgements, with self-esteem and hopelessness as potential mediators of this association. 
However, the evidence that stigma affects future recovery judgements is less clear; in the case of 
KSS total scores there is some evidence that this may be the case but there was no evidence of 
mediation by self-esteem and hopelessness. 
 
3.2.3 PANSS symptoms 
 
Table 3 shows the results of the multiple regressions for PANSS subscales and items at 
baseline. As with the subjective recovery analyses, the stigma variable was entered first and then the 
self-esteem and hopelessness measures were entered afterwards. Stigma predicted PANSS Positive 
subscale scores, F[1,71] = 4.36, p <.05, adjusted R2 = .05, but, when self-esteem and hopelessness 
were entered into the model, the model improved, F[2,69]change = 8.37, p <.01, leading to a final 
significant model, F[3,69] = 7.33, p <.001, adjusted R2 =.24, whereby self-esteem and hopelessness 
both became significant predictors and effect of stigma was no longer significant. 
 
                                                       INSERT TABLE 3  
 
Stigma further predicted PANSS item P6 (suspiciousness/persecution), F[1,71]=10.96, p <.01, 
adjusted R2 =.12, however, when self-esteem and hopelessness were added to the model, the model 
improved, F[2,69]change =9.36, p <.001, leading to a final significant model, F[3,69]= 10.76, p <.001, 
adjusted R2 =.29, where self-esteem and hopelessness both became significant predictors of PANSS 
item P6, and stigma no longer had a significant effect. 
Similarly, stigma predicted PANSS item G16 (active social avoidance), F[1,71]=7.75, p <.01, 
adjusted R2 =.10. When self-esteem and hopelessness were entered into the model, the model 
improved, F[2,69]change=12.99, p <.001. This led to a final significant model, F[3,69]=12.11, p <.001, 
adjusted R2 =.32, with self-esteem and hopelessness significantly predicting G16, and the effect of 
stigma becoming non-significant. However, stigma did not predict PANSS item N4 (passive social 
withdrawal) or G3 (guilt feelings). 
Overall, these findings suggest that current experiences of stigma strongly predict positive 
symptoms, particularly suspiciousness and persecution; and active social avoidance. Moreover self-
esteem and hopelessness may potentially mediate this relationship.  
 For symptomatic recovery at 6 months follow-up we included baseline symptomatic 
recovery scores in the first stage in order to control for their effect. Stigma was added in the second 
stage, and self-esteem and hopelessness were added in at the third stage. Stigma did not predict 
PANSS positive subscale scores or P6 (suspiciousness) at 6 months but it did predict three of the 
individual PANSS items in ways that were consistent with our predictions. 
 Despite the lack of association between stigma and passive social withdrawal (N4) at 
baseline, N4 at 6 months was unexpectedly predicted by total stigma, F [1,51] = 9.20, p < .005, 
adjusted R2=.18,  when baseline PANSS N4 data was controlled for. When self-esteem and 
hopelessness were added into the model, the model improved, F [2,49]change = 3.95, p <.05, leading 
to a final model, F[4,49]=5.73, p <.01, adjusted R2=.26, where self-esteem (but not hopelessness) 
became significant and stigma was no longer significant.  
 Active social avoidance (G16) was also significantly predicted by total stigma F [1,51] = 4.03, 
p ≤.05, adjusted R2=.41 after controlling for baseline scores. The addition of self-esteem and 
hopelessness did not improve the model. Similarly, guilt feelings (G3) was predicted by total stigma, 
F[1,51] = 7.49, p <.01, adjusted R2=.33, but the addition of self-esteem and hopelessness in the third 
stage had no significant effect and the model did not improve. 
 In summary, there was evidence that stigma at baseline predicted passive social withdrawal, 
active social avoidance and guilt feelings at six month follow-up. The effect of stigma on passive 
social withdrawal may be mediated by self-esteem and hopelessness. 
 
3.3. Multiple mediation analysis 
 Multiple mediation analyses were carried out to further interrogate the data where the 
regression analyses indicated that they might be appropriate. In these analyses, we looked at the 
effects of the individual KSS subscales (discrimination and disclosure), in each case controlling for the 
remaining subscale and, in the case of 6-month follow-up data, baseline scores on the QPR or 
appropriate PANSS measure; see Figure 1. Detailed statistical results are available in online 
supplementary tables S1 (for baseline data) and S2 (6 month follow-up data).   
                                                                     INSERT FIG 1 
 At baseline, the effect of total KSS scores on subjective recovery was fully mediated by both 
low self-esteem (specific indirect effect B = -.16, 95% CI = -.28 ─ -.05) and hopelessness (B = -.12, 95% 
CI = -.25 ─ -.04). The effect on PANSS positive scores was fully mediated by hopelessness (B = .05, 
95% CI = .00 ─ .10) and not self-esteem. When individual PANSS items were examined, the effect on 
suspiciousness (P6) was fully mediated through self-esteem (B =.02, 95% CI = .01 ─ .03) as was active 
G16 social avoidance (B =.02, 95% CI = .00 ─ .04). The effect of total stigma on N4 passive social 
withdrawal was fully mediated through hopelessness (B =.01, 95% CI = .00 ─ .03). When the KSS 
subscales discrimination and disclosure were entered together as predictors, substantially similar 
results were obtained with the exception of the analysis for QPR, the effect of disclosure was only 
mediated through hopelessness, and the effect of discrimination was only partially mediated 
through both self-esteem and hopelessness (there was a residual direct effect of discrimination on 
QPR scores). 
 For the 6-month follow-up data, only N4 passive social withdrawal showed evidence of 
mediation in our regression models. In the case of total KSS scores, the association between stigma 
and outcome was fully mediated by self-esteem (B = .01, 95% CI = .00 ─ .04). When the individual 
KSS subscales were considered, the effect of discrimination was fully mediated by self-esteem (B = 
.03, 95% CI = .01 ─ .07) but there was no effect for disclosure. 
 
4. Discussion 
The primary aim of the study was to examine whether internalised stigma had a negative impact on 
subjective and symptomatic recovery. Previous research has suggested that this may be the case 
through a number of pathways, for example reduced help-seeking (Thornicroft et al., 2007), reduced 
social functioning and engagement (Link et al., 1997b, 2001; Thornicroft et al., 2007) and reduced 
life opportunities (Thornicroft et al., 2009).  However, whilst it is clear that internalised stigma 
affects a number of aspects of recovery, the underlying processes and the nature of these 
relationships requires further clarification.  
The results of this study suggest that both subjective recovery judgments and symptoms 
may be affected. At baseline, experiences of internalised stigma strongly predicted poor recovery 
judgements. Similarly, internalised stigma appeared to predict positive symptoms, particularly 
suspiciousness and persecution, and active social avoidance. At 6 month follow up, active social 
avoidance, guilt feelings and self-blame were predicted by internalised stigma. Passive social 
withdrawal was also longitudinally predicted by internalised stigma, and by discrimination. The 
effect of stigma and discrimination on passive social withdrawal at six months appeared to be 
mediated by self-esteem. The effect of internalised stigma on baseline recovery judgements 
appeared to be mediated through low self-esteem and hopelessness. However, neither self-esteem 
nor hopelessness appeared to explain the persisting association between internalised stigma and 
long-term recovery judgements (as discussed below, this might be because there was a long gap 
between the measurement of these mediators and the six-month outcome). 
Previous research has highlighted one aspect of the relationship between positive symptoms 
and internalised stigma, suggesting that more positive symptoms result in more experiences of 
internalised stigma (Lysaker et al., 2007a). Our results found evidence that the relationship also 
works in the opposite direction, with internalised stigma experiences affecting positive symptoms. 
Our results were consistent with previous work which has described feelings of guilt and shame as 
integral to the internalisation of stigma (Corrigan and Watson, 2002) as we found that guilt feelings 
and self-blame were predicted by stigma at 6 month follow-up in our regression analyses. However, 
it is difficult to determine to what extent the guilt feelings are related to the causes or the 
consequences of mental illness without examining the content of the feelings expressed. For 
example, research suggests that service users with psychosis are 2.72 times more likely to have been 
exposed to childhood adversity than the general population (Varese et al., 2012) and self-blame is 
well-documented in victims of trauma (Coffey et al., 1996). Therefore, whilst we cannot assume that 
internalised stigma is the sole predictor of guilt and self-blame, it clearly has a significant effect on 
this experience in people with psychosis. 
 The negative effects of stigma on social interaction have often been observed (Link et al., 
1997b, 2001; Thornicroft et al., 2007), but it was interesting to find in our data that the effects of 
internalised stigma at baseline were still significant six months later. Active social avoidance is 
characterised by diminished social involvement consequent on unwarranted fear, hostility, or 
distrust. The long-term effects apparent in the data suggests that patients may be self-stigmatising 
and pre-emptively withdrawing from social interaction in the anticipation of experiencing negative 
reactions from others. This finding is consistent with previous findings from Yanos et al. (2008), who, 
in a cross-sectional study, found that internalised stigma increases avoidant coping and active social 
avoidance. Yanos et al. further found hope and self-esteem to be influential in this relationship; 
however we only found self-esteem to have a mediating effect between experienced stigma and 
active social avoidance at baseline, whereas hopelessness mediated the effect on passive avoidance. 
Contrastingly, at 6 months the effect of stigma on passive (but not active) social withdrawal was 
mediated by low self-esteem. These discrepancies between the role of self-esteem and hopelessness 
at the different time points may be less important than they at first appear; the two variables were 
measured at the same time point at the beginning of the study and were moderately correlated; 
hence, it may have been difficult for our design to discriminate between these different facets of a 
pessimistic cognitive style.  
Neither self-esteem nor hopelessness were able to explain the persisting association 
between internalised stigma and long-term recovery judgements. It is possible that this finding 
reflects a study limitation, as only the recovery measures and not the mediators were repeated at 
the six month follow up. Perhaps mediation would have been detected had self-esteem and 
hopelessness been assessed closer to the 6-month follow-up point. Previous research has shown 
that perceived discrimination and stigma strongly predict future self-esteem at 6 months and 24 
months (Link et al., 2001, 2004), although no comparable data is available for hopelessness. It is also 
possible that the effects of perceived stigma are cumulative as an individual may have more 
discriminatory experiences over time; in which case the association between internalised stigma, 
self-esteem and hopelessness may have an even greater impact on recovery judgements long-term if 
six-month data were available for all measures.  
 Nevertheless, for both subjective recovery and symptoms at baseline, and for symptoms at 
six month follow-up, it is evident that hopelessness and low self-esteem play a key role in facilitating 
the effects of stigma. Overall, the findings are consistent with existing research which suggests that 
stigma causes loss of self-esteem (Link et al., 2001) and hope (González-Torres et al., 2007), and can 
impede recovery. There are several limitations of the present study that might be addressed in 
future research. First, as noted, the mediating psychological mechanisms were measured only at 
baseline and it would have been preferable to repeat them at follow-up, which might include several 
time points. Secondly, we deliberately invited a broad range of patients to take part in the hope of 
sampling a range of symptom profiles and recovery judgments. An alternative approach might have 
been to select patients experiencing their first episode (or even during the prodromal period before 
first onset) to understand how stigma evolves across the course of illness, and the extent to which 
stigma impedes recovery. Third, stigma is clearly a multi-faceted construct and there are aspects 
that we have not measured; for example there has recently been interest in implicit measures of 
stigma (Teachman et al., 2006; Rüsch et al., 2010). Finally, the KSS is time-nonspecific (items do not 
specify whether stigma is experienced in the present or the past); future studies which address the 
question of whether stigma fluctuates over time may be better able to address associations with 
self-esteem, hopelessness and symptoms which, undoubtedly, also fluctuate. 
 Nonetheless, our findings have some important clinical implications. Whilst there are 
numerous anti-stigma campaigns which target stigma on a societal level (Wood et al., 2014b) they 
have had varying success with some campaigns resulting in increased desire for social distance from 
individuals with mental health problems (Read et al., 2006, 2013). It is important in light of our 
existing knowledge about self-stigma to target stigma not only on the population level, but also on 
an individual level in order to equip individuals so that they can deal with stigma in a way that is less 
injurious to their self-perception and sense of recovery.  Our results suggest that the mediators of 
self-esteem and hopelessness are crucial targets for interventions at a personal level. Moreover, a 
focus on how internalised stigma is handled, encouraging social participation and preventing 
isolation is important for wellbeing and symptomatic recovery in the long-run (Garety et al., 2000, 
2001; Pyle and Morrison, 2013; Wood et al., 2014a).  
NICE (National Institute for Health and Care Excellence, 2009) recommends Cognitive 
Behavioural Therapy (CBT) as the first line of psychological intervention for psychosis. Research has 
shown that CBT shows promise in terms of improving self-esteem in clients with psychosis (Hall and 
Tarrier, 2003) and it has been suggested that it would be the most appropriate approach to 
addressing issues such as feelings of hopelessness regarding recovery (Yanos et al., 2008; Wood et 
al., 2014b) Moreover, when CBT is utilised as a group therapy there is preliminary evidence from 
uncontrolled studies to suggest it may be successful at reducing internalised stigma, improving self-
esteem, and advancing recovery (Knight et al., 2003; MacInnes and Lewis, 2008; Lucksted et al., 
2011), and a recent randomised controlled trial found that a cognitive behavioural self-stigma 
reduction programme had significant benefits on self-esteem(Fung et al., 2011). Other interventions 
that aim to promote optimism and improve self-esteem, such as peer support, may also be worth 
evaluating in terms of effects on internalised stigma (Pyle and Morrison, 2013). 
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Table 1 
Mean, reliabilities and Pearson’s inter-correlations for all variables in the multiple mediation models of the effects of stigma on recovery. 
              Measure n α 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1. Total Stigma 73 .86 -              
2. Discrimination 73 .79 .80** -             
3. Disclosure 73 .84 .86** .40** -            
4. Positive Aspects 73 .34 .58** .26* .48** -           
5. Hopelessness  74 .92 .54** .47** .40** .40** -          
6. Negative Self Esteem 74 .91 .53** .49** .37** .40** .70** -         
7. Positive Self Esteem 74 .89 -.45** -.42** -.30** -.38** -.56** -.58** -        
8. QPR Baseline 78 .90 -.41** -.23* -.40** -.38** -.62** -.60** .53** -       
9. QPR 6 Months 52 .87 -.43** -.41** -.30* -.34* -.59** -.49** .58** .65** -      
10. PANSS Positive Baseline 79 .59 .24* .23 .19 .07 .46** .39** -.40** -.52** -.52** -     
11. PANSS Positive 6 Months 54 .67 .21 .27* .12 .02 .49** .44** -.36** -.55** -.63** .71** -    
12. PANSS Negative Baseline 79 .74 .23 .20 .16 .20 .34** .34** -.43** -.39** -.38** .46** .46** -   
13. PANSS Negative 6 Months 54 .74 .15 .05 .16 .24 .25 .10 -.38** -.24 -.30* .29* .43** .65** -  
14. PANSS General Baseline 80 .69 .46** .44** .34** .22 .64** .58** -.51** -.57** -.55** .64** .50** .63** .40** - 
15. PANSS General 6 Months 54 .80 .35** .37** .22 .23 .57** .52** -.41** -.55** -.70** .51** .77** .53** .49** .68** 
Notes: Total Stigma = KSS Total score, Discrimination = KSS discrimination sub-scale, Disclosure = KSS disclosure sub-scale, Positive Aspects = KSS positive 
aspects of stigma sub-scale, Hopelessness = BHS, Negative Self Esteem = Negative sub-scale of SERS, Positive Self Esteem = Positive sub-scale of SERS. 
*p≤0.05; **p≤0.01, α = Cronbach’s alpha coefficient.  
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Table 2 
Multiple regressions for subjective recovery at baseline and 6-month follow-up. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Subjective 
Recovery at 
Baseline 
Model 1 
Subjective Recovery 
at Baseline 
Model 2 
   
Variable B Std. 
Error 
β B Std. 
Error 
β    
Total Stigma -
.27 
.07 -
.41*** 
.01 .07 .02    
Self-Esteem    3.89 1.21 .42**    
Hopelessness    -.58 .22 -.34**    
          
Discrimination -
.29 
.14 -.23* .29 .13 .23*    
Self-Esteem    4.64 1.17 .50***    
Hopelessness    -.66 .21 -.39**    
          
Disclosure -
.46 
.13 -
.40*** 
-.15 .11 -.13    
Self-Esteem    3.59 1.15 .39**    
Hopelessness    -.50 .21 -.30*    
          
 Subjective 
Recovery at 6 
Months 
Model 1 
Subjective Recovery 
at 6 Months 
Model 2 
Subjective 
Recovery at 6 
Months 
Model 3 
Variable B Std. 
Error 
β B Std. 
Error 
β B Std. 
Error 
β 
Baseline .72 .12 .65*** .63 .12 .57*** .42 .16 .38** 
Total Stigma    -.18 .09 -.24* -.10 .09 -.13 
Self-Esteem       2.12 1.69 .20 
Hopelessness       -.30 .30 -.16 
          
Baseline  .72 .12 .65*** .64 .12 .58*** .48 .16 .44** 
Discrimination    -.41 .15 -.29** -.24 .19 -.17 
Self-Esteem       1.66 1.80 .15 
Hopelessness       -.25 .31 -.13 
          
Baseline .72 .12 .65*** .69 .13 .62*** .40 .16 .36* 
Disclosure    -.13 .16 -.09 -.11 .15 -.08 
Self-Esteem       2.62 1.63 .24 
Hopelessness       -.35 .30 -.18 
          
 Positive PANSS Suspiciousness/P
ersecution 
Passive Social 
Withdrawal 
Guilt Feelings Active Social 
Avoidance 
Table 3 
Multiple regressions for PANSS sub-scale and items at baseline. 
Note: Positive PANSS = PANSS Positive sub-scale, Suspiciousness/Persecution = PANSS item P6,  
Passive Social Withdrawal = PANSS item N4, Guilt Feelings = PANSS item G3, Active Social Avoidance 
= PANSS item G16, Total Stigma = KSS Total Score, Discrimination = KSS discrimination sub-scale, 
Disclosure = KSS disclosure sub-scale, Self-Esteem = SERS factor, Hopelessness = BHS. *p≤.05, 
**p≤.01, ***p≤.001. 
 
 
 B Std. 
Error 
β B Std. 
Error 
β B Std. 
Error 
β B Std. 
Error 
β B Std. 
Error 
β 
Model 1                
Total 
Stigma 
.7
1 
.03 .24
* 
.0
4 
.01 .37
*** 
.0
1 
.01 .19 .0
2 
.01 .22 .0
3 
.01 .31*
* 
                
Discrimi
nation 
.1
3 
.07 .23
* 
.0
6 
.02 .34
** 
.0
4 
.02 .26
* 
.0
6 
.02 .31
** 
.0
4 
.02 .24* 
                
Disclosu
re 
.1
0 
.06 .19 .0
5 
.02 .29
** 
.0
7 
.02 .06 .0
3 
.021 .14 .0
4 
.02 .27* 
                
Model 2                
Total 
Stigma 
-
.0
2 
.04 -
.08 
.0
1 
.01 .05 -
.0
1 
.01 -
.14 
.0
1 
.01 .03 -
.0
0 
.01 -.05 
Self-
esteem 
-
1.
07 
.65 -
.26 
-
.4
8 
.20 -
.35
* 
-
.2
7 
.16 -
.26 
-
.3
1 
.24 -
.22 
-
.5
7 
.18 -
.47*
* 
Hopeles
sness 
.2
4 
.12 .32
* 
.0
6 
.04 .23 .0
6 
.03 .34
* 
.0
3 
.04 .13 .0
4 
.03 .19 
                
Discrimi
nation 
-
.0
2 
.07 -
.04 
.0
1 
.02 .06 .0
0 
.02 .01 .0
3 
.03 .18 -
.0
2 
.02 -.10 
Self-
esteem 
-
1.
02 
.65 -
.25 
-
.4
7 
.20 -
.35
* 
-
.2
1 
.16 -
1.3
3 
-
.2
4 
.23 -
.17 
-
.5
9 
.18 -
.48*
** 
Hopeles
sness 
.2
3 
.12 .31
* 
.0
6 
.04 .23 .0
6 
.03 .30
* 
.0
3 
.04 .10 .0
4 
.03 .19 
                
Disclosu
re 
-
.0
1 
.06 -
.02 
.0
1 
.02 .07 -
.0
2 
.02 -
.18 
-
.0
0 
.02 -
.01 
.0
1 
.02 .04 
Self-
esteem 
-
.9
7 
.63 -
.24 
-
.4
8 
.19 -
.35
* 
-
.2
5 
.15 -
1.6
3 
-
.3
3 
.23 -
.23 
-
.5
4 
.17 -
.44*
* 
Hopeles
sness 
.2
3 
.12 .30
* 
.0
6 
.04 .22 .0
7 
.03 .35
* 
.0
4 
.04 .14 .0
4 
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Figure 1 
Mediation models 1 and 2 
Note: Model 1 was run for PANSS and QPR at baseline and at 6 months. Self-Esteem = SERS 
factor, Hopelessness = BHS, Discrimination = KSS discrimination sub-scale, Disclosure = KSS 
disclosure sub-scale, Recovery = QPR, or PANSS subscale, or PANSS item at baseline or at 6 
month follow-up.  
Note: Model 2 was run for PANSS and QPR at baseline and at 6 months. Self-Esteem = SERS 
factor, Stigma = KSS total, Recovery = QPR, or PANSS subscale, or PANSS item at baseline or at 6 
month follow-up.  
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Table S1 
Results from the mediation analyses for baseline data. 
 95% Confidence Interval 
Effect B Std. Error Lower Upper 
Baseline Model 1      
Direct Effects (path a)     
KSSTotal → SERS -.04*** .01 -.05 -.03 
KSSTotal → BHS .22*** .04 .14 .29 
     
Direct Effects (path b)     
SERS → QPR 3.89** 1.21 1.47 6.31 
BHS→ QPR -.58** .22 -1.01 -.14 
SERS→ PANSS+ -1.07 .65 -2.36 .22 
BHS→ PANSS+ .24* .12 .01 .48 
SERS→ P6 -.48* .20 -.88 -.08 
BHS→ P6 .06 .04 -.02 .13 
SERS→ G16 -.57** .18 -.92 -.22 
BHS→ G16 .04 .03 -.02 .11 
SERS→ N4 -.26 .16 -.58 .05 
BHS→ N4 .06* .03 -.03 .01 
     
Direct Effects (path c’)     
KSSTotal → QPR .01 .07 -.13 .16 
KSSTotal → PANSS+ -.02 .39 -.11 .05 
KSSTotal → P6 .01 .01 -.02 .03 
KSSTotal → G16 -.00 .01 -.03 .02 
KSSTotal → N4 -.01 .01 -.03 .01 
     
Specific Indirect Effects of Stigma     
KSSTotal → SERS → QPR -.16* .06 -.28 -.05 
KSSTotal → BHS → QPR -.12* .05 -.25 -.04 
KSSTotal → SERS → PANSS+ .04 .03 -.01 .10 
KSSTotal → BHS → PANSS+ .05* .02 .00 .10 
KSSTotal → SERS → P6 .02* .01 .01 .03 
KSSTotal → BHS → P6 .01 .01 -.01 .03 
KSSTotal → SERS → G16 .02* .01 .00 .04 
KSSTotal → BHS → G16 .01 .01 -.01 .03 
KSSTotal → SERS → N4 .01 .01 -.01 .03 
KSSTotal → BHS → N4 .01* .01 .00 .03 
     
Baseline Model 2      
Direct Effects (path a)     
Discrimination → SERS -.06*** .01 -.09 -.33 
Discrimination → BHS .29** .08 .13 .45 
Disclosure → SERS -.02 .01 -.05 .00 
Disclosure → BHS .17* .07 .02 .32 
     
Direct Effects (path b)     
SERS → QPR 4.46*** 1.15 2.16 6.76 
BHS → QPR -.59** .21 -1.00 -.18 
7. Optional e-only supplementary files
Note: PANSS+ = PANSS Positive sub-scale, P6 = PANSS item for suspiciousness/persecution,  N4 = 
PANSS item for Passive Social Withdrawal, G16 = PANSS item for Active Social Avoidance, QPR = 
Subjective recovery (at baseline), KSS Total = Total stigma score, Discrimination = KSS discrimination 
sub-scale, Disclosure = KSS disclosure sub-scale, SERS = Self-esteem, BHS = Hopelessness. *p≤.05, 
**p≤.01, ***p≤.001. 
 
 
SERS → PANSS+ -1.03 .65 -2.33 .28 
BHS → PANSS+ .23* .12 -.00 .47 
SERS → P6 -.47* .20 -.87 -.06 
BHS → P6 .05 .04 -.02 .13 
SERS → G16 -.58*** .18 -.94 -.23 
BHS → G16 .04 .03 -.02 .10 
SERS→ N4 -.23 .16 -.55 .09 
BHS → N4 .06* .03 .01 .12 
     
Direct Effects (path c’)     
Discrimination → QPR .34** .13 .08 .59 
Disclosure → QPR -.20 .11 -.42 .01 
Discrimination → PANSS+ -.02 .07 -.17 .12 
Disclosure → PANSS+ -.01 .06 -.13 .12 
Discrimination → P6 .01 .02 -.04 .05 
Disclosure → P6 .01 .02 -.03 .05 
Discrimination → G16 -.02 .02 -.06 .02 
Disclosure → G16 .01 .02 -.02 .04 
Discrimination → N4 .01 .02 -.03 .04 
Disclosure → N4 -.02 .02 -.05 .01 
     
Specific Indirect Effects of Stigma     
Discrimination → SERS→ QPR -.28* .10 -.52 -.11 
Discrimination → BHS → QPR -.17* .07 -.36 -.06 
Disclosure → SERS → QPR -.11* .06 -.27 -.01 
Disclosure → BHS → QPR -.11* .06 -.26 -.02 
Discrimination → SERS→ PANSS+ .06 .04 -.02 .16 
Discrimination → BHS → PANSS+ .06* .03 .01 .15 
Disclosure → SERS → PANSS+ .03 .02 -.00 .10 
Disclosure → BHS → PANSS+ .04* .02 .01 .10 
Discrimination → SERS→ P6 .03* .01 .01 .06 
Discrimination → BHS → P6 .01 .01 -.00 .04 
Disclosure → SERS → P6 .01* .01 .00 .04 
Disclosure → BHS → P6 .01 .01 -.00 .03 
Discrimination → SERS→ G16 .03* .02 .01 .08 
Discrimination → BHS → G16 .01 .01 -.01 .04 
Disclosure → SERS → G16 .02* .01 .01 .04 
Disclosure → BHS → G16 .01 .01 -.01 .04 
Discrimination → SERS→ N4 .01 .01 -.01 .04 
Discrimination → BHS → N4 .02* .01 .00 .05 
Disclosure → SERS → N4 .01 .01 -.00 .03 
Disclosure → BHS → N4 .01* .01 .00 .03 
Table S2  
Results from the mediation analyses for 6 month follow-up. 
 95% Confidence Interval 
Effect B Std. Error Lower Upper 
6 Month Model 1      
Direct Effects (path a)     
KSSTotal → SERS -.03*** .01 -.05 -.02 
KSSTotal → BHS .17** .05 .06 .27 
     
Direct Effects (path b)     
SERS → QPR 3.42* 1.65 .11 6.74 
BHS→ QPR -.56 .29 -1.15 .04 
SERS→ N4 -.42* .19 -.79 -.04 
BHS→ N4 .02 .03 -.05 .08 
     
Direct Effects (path c’)     
KSSTotal → QPR -.12 .09 -.30 .07 
KSSTotal → N4 .01 .01 -.01 .03 
     
Specific Indirect Effects of Stigma     
KSSTotal → SERS → QPR -.12 .09 -.36 .01 
KSSTotal → BHS → QPR -.09 .06 -.23 .00 
KSSTotal → SERS → N4 .01* .01 .00 .04 
KSSTotal → BHS → N4 .00 .01 -.01 .02 
     
6 Month Model 2      
Direct Effects (path a)     
Discrimination → SERS -.07*** .02 -.11 -.04 
Discrimination → BHS .34** .11 .13 .56 
Disclosure → SERS .00 .02 -.03 .04 
Disclosure → BHS .02 .10 -.19 .23 
     
Direct Effects (path b)     
SERS → QPR 3.70* 1.69 .30 7.11 
BHS → QPR -.56 .30 -1.16 .04 
SERS→ N4 -.47* .19 -.85 -.09 
BHS → N4 .02 .03 -.05 .04 
     
Direct Effects (path c’)     
Discrimination → QPR -.04 .20 -.44 .37 
Disclosure → QPR -.19 .17 -.53 .16 
Discrimination → N4 -.01 .02 -.05 .04 
Disclosure → N4 .03 .01 -.01 .07 
     
Specific Indirect Effects of Stigma     
Discrimination → SERS→ QPR -.27 .17 -.73 -.03 
Discrimination → BHS → QPR -.19 .13 -.51 .03 
Disclosure → SERS → QPR .01 .06 -.12 .14 
Disclosure → BHS → QPR -.01 .07 -.17 .12 
Discrimination → SERS→ N4 .03* .01 .01 .07 
Note: QPR = Subjective recovery (at six month follow-up), KSSTotal = Total stigma score, 
Discrimination = KSS discrimination sub-scale, Disclosure = KSS disclosure sub-scale, SERS = Self-
esteem, BHS = Hopelessness. *p≤.05, **p≤.01, ***p≤.001. 
Discrimination → BHS → N4 .01 .01 -.02 .03 
Disclosure → SERS→ N4 -.00 .01 -.01 .02 
Disclosure → BHS → N4 .00 .00 -.01 .02 
     
